{"disease":{"id":"mycobacterium-infections-nontuberculous","name":"mycobacterium infections nontuberculous"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02832843","title":"Genome-Wide Association Study in Patients With Nontuberculous Mycobacterial Lung Disease","phase":"","overall_status":"COMPLETED","enrollment_count":2808,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT04677569","title":"Study to Evaluate ALIS (Amikacin Liposome Inhalation Suspension) in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":425,"lead_sponsor_name":"Insmed Incorporated","has_results":false},{"nct_id":"NCT02344004","title":"Study to Evaluate Efficacy of LAI When Added to Multi-drug Regimen Compared to Multi-drug Regimen Alone","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":336,"lead_sponsor_name":"Insmed Incorporated","has_results":true},{"nct_id":"NCT06418711","title":"ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":132,"lead_sponsor_name":"Mannkind Corporation","has_results":false},{"nct_id":"NCT04677543","title":"Validation of Patient Reported Outcome Measures in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":99,"lead_sponsor_name":"Insmed Incorporated","has_results":true},{"nct_id":"NCT01315236","title":"Liposomal Amikacin for Inhalation (LAI) for Nontuberculous Mycobacteria","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"Insmed Incorporated","has_results":true},{"nct_id":"NCT04922554","title":"Oral Omadacycline vs. Placebo in Adults With NTM Pulmonary Disease Caused by Mycobacterium Abscessus Complex (MABc)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":66,"lead_sponsor_name":"Paratek Pharmaceuticals Inc","has_results":true},{"nct_id":"NCT07094711","title":"Safety, Immunogenicity, and Efficacy of Therapeutic Mycobacterium Bovis BCG (BOOST)","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":48,"lead_sponsor_name":"University of Virginia","has_results":false},{"nct_id":"NCT03421743","title":"Pilot Trial of Inhaled Molgramostim in Non-tuberculous Mycobacterial (NTM) Infection","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Savara Inc.","has_results":true},{"nct_id":"NCT03597347","title":"Trial of Inhaled Molgramostim in Cystic Fibrosis Subjects With Nontuberculous Mycobacterial Infection","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":14,"lead_sponsor_name":"Savara Inc.","has_results":true},{"nct_id":"NCT04154826","title":"Recombinant Interleukin-7 (CYT107) to Treat Patients With Refractory Nontuberculous Mycobacterial Lung Disease","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":8,"lead_sponsor_name":"Revimmune","has_results":false}],"total":11},"guidelines":[],"source":"Drug Landscape verified database"}